Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy

European Heart Journal

Volumn 18, Issue 6, 1997, Pages 1024-1029

  Abdallah, A N ^a   Billes, M A ^a   Attia, Y ^a   Doutremepuich, C ^a   Cassaigne, A ^a   Iron, A ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cardiac transplantation; Heart graft rejection; Interleukin 6; Tumour necrosis factor alpha

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL;

EID: 0031006217     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a015361     Document Type: Article

References (25)